Serveur d'exploration H2N2

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Synthesis and Immunogenicity Assessment of Elastin-Like Polypeptide-M2e Construct as an Influenza Antigen

Identifieur interne : 000662 ( Main/Exploration ); précédent : 000661; suivant : 000663

Synthesis and Immunogenicity Assessment of Elastin-Like Polypeptide-M2e Construct as an Influenza Antigen

Auteurs : Rohan S. Ingrole [États-Unis] ; Wenqian Tao [États-Unis] ; Jatindra N. Tripathy [États-Unis] ; Harvinder S. Gill [États-Unis]

Source :

RBID : PMC:4376021

Abstract

The 23 amino acid-long extracellular domain of the influenza virus transmembrane protein M2 (M2e) has remained highly conserved since the 1918 pandemic, and is thus considered a good candidate for development of a universal influenza A vaccine. However, M2e is poorly immunogenic. In this study we assessed the potential of increasing immunogenicity of M2e by constructing a nanoscale-designed protein polymer containing the M2e sequence and an elastin-like polypeptide (ELP) nanodomain consisting of alanine and tyrosine guest residues (ELP(A2YA2)24). The ELP nanodomain was included to increase antigen size, and to exploit the inherent thermal inverse phase transition behavior of ELPs to purify the protein polymer. The ELP(A2YA2)24 + M2e nanodomained molecule was recombinantly synthesized. Characterization of its inverse phase transition behavior demonstrated that attachment of M2e to ELP(A2YA2)24 increased its transition temperature compared to ELP(A2YA2)24. Using a dot blot test we determined that M2e conjugated to ELP is recognizable by M2e–specific antibodies, suggesting that the conjugation process does not adversely affect the immunogenic property of M2e. Further, upon vaccinating mice with ELP(A2YA2)24 + M2e it was found that indeed the nanodomained protein enhanced M2e–specific antibodies in mouse serum compared to free M2e peptide and ELP(A2YA2)24. The immune serum could also recognize M2 expressed on influenza virions. Overall, this data suggests the potential of using molecules containing M2e–ELP nano-domains to develop a universal influenza vaccine.


Url:
DOI: 10.1142/s1793984414500044
PubMed: 25825595
PubMed Central: 4376021


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Synthesis and Immunogenicity Assessment of Elastin-Like Polypeptide-M2e Construct as an Influenza Antigen</title>
<author>
<name sortKey="Ingrole, Rohan S" sort="Ingrole, Rohan S" uniqKey="Ingrole R" first="Rohan S." last="Ingrole">Rohan S. Ingrole</name>
<affiliation wicri:level="1">
<nlm:aff id="A1">Department of Chemical Engineering Texas Tech University, 6th and Canton Lubbock, Texas 79409, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Chemical Engineering Texas Tech University, 6th and Canton Lubbock, Texas 79409</wicri:regionArea>
<wicri:noRegion>Texas 79409</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Tao, Wenqian" sort="Tao, Wenqian" uniqKey="Tao W" first="Wenqian" last="Tao">Wenqian Tao</name>
<affiliation wicri:level="1">
<nlm:aff id="A1">Department of Chemical Engineering Texas Tech University, 6th and Canton Lubbock, Texas 79409, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Chemical Engineering Texas Tech University, 6th and Canton Lubbock, Texas 79409</wicri:regionArea>
<wicri:noRegion>Texas 79409</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Tripathy, Jatindra N" sort="Tripathy, Jatindra N" uniqKey="Tripathy J" first="Jatindra N." last="Tripathy">Jatindra N. Tripathy</name>
<affiliation wicri:level="1">
<nlm:aff id="A2">Center for Biotechnology and Genomics Texas Tech University Lubbock, Texas 79409, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Center for Biotechnology and Genomics Texas Tech University Lubbock, Texas 79409</wicri:regionArea>
<wicri:noRegion>Texas 79409</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Gill, Harvinder S" sort="Gill, Harvinder S" uniqKey="Gill H" first="Harvinder S." last="Gill">Harvinder S. Gill</name>
<affiliation wicri:level="1">
<nlm:aff id="A1">Department of Chemical Engineering Texas Tech University, 6th and Canton Lubbock, Texas 79409, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Chemical Engineering Texas Tech University, 6th and Canton Lubbock, Texas 79409</wicri:regionArea>
<wicri:noRegion>Texas 79409</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">25825595</idno>
<idno type="pmc">4376021</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376021</idno>
<idno type="RBID">PMC:4376021</idno>
<idno type="doi">10.1142/s1793984414500044</idno>
<date when="2014">2014</date>
<idno type="wicri:Area/Pmc/Corpus">000833</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000833</idno>
<idno type="wicri:Area/Pmc/Curation">000833</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000833</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000449</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000449</idno>
<idno type="wicri:Area/Ncbi/Merge">000B53</idno>
<idno type="wicri:Area/Ncbi/Curation">000B53</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000B53</idno>
<idno type="wicri:doubleKey">1793-9844:2014:Ingrole R:synthesis:and:immunogenicity</idno>
<idno type="wicri:Area/Main/Merge">000663</idno>
<idno type="wicri:Area/Main/Curation">000662</idno>
<idno type="wicri:Area/Main/Exploration">000662</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Synthesis and Immunogenicity Assessment of Elastin-Like Polypeptide-M2e Construct as an Influenza Antigen</title>
<author>
<name sortKey="Ingrole, Rohan S" sort="Ingrole, Rohan S" uniqKey="Ingrole R" first="Rohan S." last="Ingrole">Rohan S. Ingrole</name>
<affiliation wicri:level="1">
<nlm:aff id="A1">Department of Chemical Engineering Texas Tech University, 6th and Canton Lubbock, Texas 79409, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Chemical Engineering Texas Tech University, 6th and Canton Lubbock, Texas 79409</wicri:regionArea>
<wicri:noRegion>Texas 79409</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Tao, Wenqian" sort="Tao, Wenqian" uniqKey="Tao W" first="Wenqian" last="Tao">Wenqian Tao</name>
<affiliation wicri:level="1">
<nlm:aff id="A1">Department of Chemical Engineering Texas Tech University, 6th and Canton Lubbock, Texas 79409, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Chemical Engineering Texas Tech University, 6th and Canton Lubbock, Texas 79409</wicri:regionArea>
<wicri:noRegion>Texas 79409</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Tripathy, Jatindra N" sort="Tripathy, Jatindra N" uniqKey="Tripathy J" first="Jatindra N." last="Tripathy">Jatindra N. Tripathy</name>
<affiliation wicri:level="1">
<nlm:aff id="A2">Center for Biotechnology and Genomics Texas Tech University Lubbock, Texas 79409, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Center for Biotechnology and Genomics Texas Tech University Lubbock, Texas 79409</wicri:regionArea>
<wicri:noRegion>Texas 79409</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Gill, Harvinder S" sort="Gill, Harvinder S" uniqKey="Gill H" first="Harvinder S." last="Gill">Harvinder S. Gill</name>
<affiliation wicri:level="1">
<nlm:aff id="A1">Department of Chemical Engineering Texas Tech University, 6th and Canton Lubbock, Texas 79409, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Chemical Engineering Texas Tech University, 6th and Canton Lubbock, Texas 79409</wicri:regionArea>
<wicri:noRegion>Texas 79409</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Nano LIFE</title>
<idno type="ISSN">1793-9844</idno>
<idno type="eISSN">1793-9852</idno>
<imprint>
<date when="2014">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p id="P1">The 23 amino acid-long extracellular domain of the influenza virus transmembrane protein M2 (M2e) has remained highly conserved since the 1918 pandemic, and is thus considered a good candidate for development of a universal influenza A vaccine. However, M2e is poorly immunogenic. In this study we assessed the potential of increasing immunogenicity of M2e by constructing a nanoscale-designed protein polymer containing the M2e sequence and an elastin-like polypeptide (ELP) nanodomain consisting of alanine and tyrosine guest residues (ELP(A
<sub>2</sub>
YA
<sub>2</sub>
)
<sub>24</sub>
). The ELP nanodomain was included to increase antigen size, and to exploit the inherent thermal inverse phase transition behavior of ELPs to purify the protein polymer. The ELP(A
<sub>2</sub>
YA
<sub>2</sub>
)
<sub>24</sub>
+ M2e nanodomained molecule was recombinantly synthesized. Characterization of its inverse phase transition behavior demonstrated that attachment of M2e to ELP(A
<sub>2</sub>
YA
<sub>2</sub>
)
<sub>24</sub>
increased its transition temperature compared to ELP(A
<sub>2</sub>
YA
<sub>2</sub>
)
<sub>24</sub>
. Using a dot blot test we determined that M2e conjugated to ELP is recognizable by M2e–specific antibodies, suggesting that the conjugation process does not adversely affect the immunogenic property of M2e. Further, upon vaccinating mice with ELP(A
<sub>2</sub>
YA
<sub>2</sub>
)
<sub>24</sub>
+ M2e it was found that indeed the nanodomained protein enhanced M2e–specific antibodies in mouse serum compared to free M2e peptide and ELP(A
<sub>2</sub>
YA
<sub>2</sub>
)
<sub>24</sub>
. The immune serum could also recognize M2 expressed on influenza virions. Overall, this data suggests the potential of using molecules containing M2e–ELP nano-domains to develop a universal influenza vaccine.</p>
</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
</list>
<tree>
<country name="États-Unis">
<noRegion>
<name sortKey="Ingrole, Rohan S" sort="Ingrole, Rohan S" uniqKey="Ingrole R" first="Rohan S." last="Ingrole">Rohan S. Ingrole</name>
</noRegion>
<name sortKey="Gill, Harvinder S" sort="Gill, Harvinder S" uniqKey="Gill H" first="Harvinder S." last="Gill">Harvinder S. Gill</name>
<name sortKey="Tao, Wenqian" sort="Tao, Wenqian" uniqKey="Tao W" first="Wenqian" last="Tao">Wenqian Tao</name>
<name sortKey="Tripathy, Jatindra N" sort="Tripathy, Jatindra N" uniqKey="Tripathy J" first="Jatindra N." last="Tripathy">Jatindra N. Tripathy</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000662 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000662 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     PMC:4376021
   |texte=   Synthesis and Immunogenicity Assessment of Elastin-Like Polypeptide-M2e Construct as an Influenza Antigen
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:25825595" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a H2N2V1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021